title: cAMP-dependent phosphorylation sites and macroscopic activity of recombinant cardiac L-type calcium channels.
abstract: The involvement of cAMP-dependent phosphorylation sites in establishing the basal activity of cardiac L-type Ca2+ channels was studied in HEK 293 cells transiently cotransfected with mutants of the human cardiac alpha1 and accessory subunits. Systematic individual or combined elimination of high consensus protein kinase A (PKA) sites, by serine to alanine substitutions at the amino and carboxyl termini of the alpha1 subunit, resulted in Ca2+ channel currents indistinguishable from those of wild type channels. Dihydropyridine (DHP)-binding characteristics were also unaltered. To explore the possible involvement of nonconsensus sites, deletion mutants were used. Carboxyl-terminal truncations of the alpha1 subunit distal to residue 1597 resulted in increased channel expression and current amplitudes. Modulation of PKA activity in cells transfected with the wild type channel or any of the mutants did not alter Ca2+ channel functions suggesting that cardiac Ca2+ channels expressed in these cells behave, in terms of lack of PKA control, like Ca2+ channels of smooth muscle cells.
authors.affiliation: Institute of Molecular Pharmacology and Biophysics, University of Cincinnati, College of Medicine, OH 45267-0828, USA.
authors.forename: G
authors.initials: G
authors.lastname: Mikala
authors.forename: U
authors.initials: U
authors.lastname: Klöckner
authors.forename: M
authors.initials: M
authors.lastname: Varadi
authors.forename: J
authors.initials: J
authors.lastname: Eisfeld
authors.forename: A
authors.initials: A
authors.lastname: Schwartz
authors.forename: G
authors.initials: G
authors.lastname: Varadi
mesh_terms: D000409:Alanine; D019943:Amino Acid Substitution; D001464:Barium / Q000378:metabolism; D001665:Binding Sites / Q000235:genetics*; D002121:Calcium Channel Blockers / Q000378:metabolism; D015220:Calcium Channels / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism*; D020746:Calcium Channels, L-Type; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000378:metabolism*; D017868:Cyclic AMP-Dependent Protein Kinases / Q000378:metabolism; D004095:Dihydropyridines / Q000378:metabolism; D006801:Humans; D007668:Kidney / Q000166:cytology / Q000196:embryology; D008565:Membrane Proteins / Q000235:genetics / Q000378:metabolism; D009124:Muscle Proteins / Q000235:genetics / Q000378:metabolism*; D016297:Mutagenesis, Site-Directed / Q000235:genetics; D009206:Myocardium / Q000737:chemistry / Q000166:cytology; D018408:Patch-Clamp Techniques; D010766:Phosphorylation; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism; D012694:Serine; D014162:Transfection
chemical_list: D002121:Calcium Channel Blockers; D015220:Calcium Channels; D020746:Calcium Channels, L-Type; D004095:Dihydropyridines; D008565:Membrane Proteins; D009124:Muscle Proteins; D011994:Recombinant Proteins; D001464:Barium; D012694:Serine; C038806:1,4-dihydropyridine; D000242:Cyclic AMP; D017868:Cyclic AMP-Dependent Protein Kinases; D000409:Alanine